A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

BACKGROUND: Ramucirumab has recently proved to be effective for advanced or recurrent gastric cancer (AGC). Ascites and peritoneal metastasis are among the most common complications of AGC. However, there are few data on the safety and efficacy of paclitaxel plus ramucirumab in patients with AGC wit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Matsumoto, Hiroshi, Kawazoe, Akihito, Shimada, Kaoru, Fukuoka, Shota, Kuboki, Yasutoshi, Bando, Hideaki, Kojima, Takashi, Ohtsu, Atsushi, Yoshino, Takayuki, Doi, Toshihiko, Shitara, Kohei
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5793350/
https://ncbi.nlm.nih.gov/pubmed/29385993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4057-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars